2nd annual otc pharma asia 2012

26
Markets of Opportunities: Where to go next? 2 nd Annual, OTC Pharma Asia, 2012 1 March 15, 2012 Dr. Milind Sabnis, MD, MBA Principal Consultant Healthcare, Asia Pacific

Upload: frost-sullivan

Post on 20-Aug-2015

2.151 views

Category:

Health & Medicine


1 download

TRANSCRIPT

Page 1: 2nd Annual OTC Pharma Asia 2012

Markets of Opportunities: Where to go next?

2nd Annual, OTC Pharma Asia, 2012

1

March 15, 2012

Dr. Milind Sabnis, MD, MBA

Principal Consultant

Healthcare, Asia Pacific

Page 2: 2nd Annual OTC Pharma Asia 2012

Agenda

• Introduction

• Global trends & impact on health care

• Key emerging OTC markets

• Summary

2

• Summary

Page 3: 2nd Annual OTC Pharma Asia 2012

GLOBAL TRENDS & IMPACT ON HEALTH CARE

3

GLOBAL TRENDS & IMPACT ON HEALTH CARE

Page 4: 2nd Annual OTC Pharma Asia 2012

From...

Provider Centric Focus Patient Centric

Centralized – Hospital Monitor De-Centralized – Shift to Community

...To

A modern healthcare system is on the horizon, demanding a paradigm shift

Healthcare Paradigm Shift

4

Invasive in general hospitals Treatment Less invasive in specialized hospitals

Treating Sickness Objective Preventing Sickness – “Wellness”

Source: Frost & Sullivan

F

M

T

O

Page 5: 2nd Annual OTC Pharma Asia 2012

Focus: moving from physicians to patientsF

M

T

O

5

Physician PatientsPatients are becoming:

• Aware of treatment/medicine choices

• Informed decision makers

• Responsible for their own health

Source: Frost & Sullivan

Page 6: 2nd Annual OTC Pharma Asia 2012

Hospital based careHospital based care Community based careCommunity based care

Innovation in hospital business models: Hospitals go virtual; development of community based care

F

M

T

O

6

Centralized model

Patient overload

Increased costs

Strain on health care resources

Decentralized model

Reduced patient load

Reduced cost

Optimum utilization of health care resources

Source: Frost & Sullivan

Page 7: 2nd Annual OTC Pharma Asia 2012

Virtual Hospitals: Shifting the Financial Gravity of the System

Healthy, Independent Living

Chronic Disease Management

Community Clinic

Doctor’s Office

100%

Assisted Living

HOME CARE

RESIDENTIAL

Qu

ali

ty o

f li

fe

Healthy, Independent Living

Chronic Disease Management

Community Clinic

Doctor’s Office

Assisted Living

Specialty Clinic

F

M

T

O

7

Cost of care per day

$1 $10 $100 $1,000 $10,000

0%

Skilled Nursing Facility

Specialty Clinic

Community Hospital

ICU

RESIDENTIAL CARE

Qu

ali

ty o

f li

fe

Skilled Nursing Facility

Specialty Clinic

Community Hospital

ICU

ACUTE CARE

Source: Frost & Sullivan

Page 8: 2nd Annual OTC Pharma Asia 2012

General HospitalGeneral Hospital Focused Focused Specialized HospitalSpecialized Hospital

Innovation in Hospital Business Models: Trends towards specialized care delivery around specific therapeutic areas

F

M

T

O

8

Value Proposition:

Don’t know what’s wrong?

– We can address any problem you bring

Value Proposition:

Need care for a specific condition?

– Specialists, experience, world-class facilities

Traditional operations

Long post operative length of stay

Specialized hospitals offering minimal invasive surgeries/ day surgeries

Reduces or eliminates length of stay

Source: Frost & Sullivan

Page 9: 2nd Annual OTC Pharma Asia 2012

Wellness of the body, the mind and the soul

Mind

Mood

Stress levels

Mental health

Sense of optimism

Attitude

Security

Safety

F

M

T

O

9

Body SoulPersonal values

Personal fulfilment

Self image / self actualization

Sight / vision

Touch & feel

Smell / breathing

Sound

Temperature

Wellness

Source: Frost & Sullivan

Page 10: 2nd Annual OTC Pharma Asia 2012

Health & Wellness: Better Health and Disease Prevention Opportunity for digestive and weight management products

The need for prevention and better general

health has driven the demand for

functional F&B products and consequently

the market for specific functional

ingredients

Global Weight Management Ingredients

563

2171

0

500

1000

1500

2000

2500

2008 2015

Re

ven

ue

s in

$ M

n

CAGR 2008-2015: 21.3%

Re

ven

ue

s in

$ M

n

CAGR 2007-2015: 25.6%

US Digestive Health Ingredients Market US Heart Health Ingredients Market

244

1310

0

350

700

1050

1400

2008 2015

10

Over the next 10 years, weight management, heart health, and

digestive health will continue to be the high growth sectors

Source: Frost & Sullivan

7500

13900

0

3000

6000

9000

12000

15000

2008 2015

Re

ven

ue

s in

$ M

n

Global Weight Management Ingredients

CAGR 2008-2015: 9.2%

Source: Frost & Sullivan

Page 11: 2nd Annual OTC Pharma Asia 2012

Health & Wellness: Better Health and Disease Prevention Opportunity for nutri-cosmetics (vitamins, hyaluronic acid, PUFA)

Skin Care, 26%

Hair Care,

Make-

Fragrances, 11%

Oral Care, 9%

Other Toiletri

es, 15%

The global personal care market in

2009 was estimated to be around

$250 Billion and expected to grow at

a CAGR of approximately 5-6% to

2015

The increasing focus on personal care not only drives

the market for active and inactive ingredients in

personal care products but also the market for

nutricosmetics

229

528

0

100

200

300

400

500

600

2008 2015

CAGR 2008-2015: ~15%

US Nutricosmetic Ingredients

Market

Re

ven

ue

s in

$ M

n

INCREASING FOCUS ON

PERSONAL CARE

F

M

T

O

11

203

330

0

50

100

150

200

250

300

350

2008 2014

CAGR 2008-2014: 7.2%

326

1066

0

200

400

600

800

1000

1200

2008 2015

CAGR 2008-2015: 18.5%

Chinese Personal Care Active

Ingredients Market

Indian Personal Care Inactive

Ingredients Market

Care, 25%

Make-Up, 14%

Others ,

50%

Omega

3 , 4%

Vitamin

s , 23%

Caroten

oids ,

23%

CAGR 2008-2015: ~15%

Nutricosmetics are Nutricosmetics are

products when ingested products when ingested

have an effect have an effect

(preventive or reactive) (preventive or reactive)

on skin, nails and hair. on skin, nails and hair.

The ingestion of The ingestion of

nutricosmetics is mainly nutricosmetics is mainly

through food through food

fortification / fortification /

supplements supplements

Re

ven

ue

s in

$ M

n

PERSONAL CARE

2008

Source: Frost & Sullivan

Page 12: 2nd Annual OTC Pharma Asia 2012

Why Wellness?

50% Percent of all diseases can be avoided and prevented by lifestyle changes

Only 31% of healthcare expenditure in organization is spent on direct medical costs

Medical Costs

Direct = 31%

Medical Costs

Workers

Indirect = 69%

Lost Productivity:- Absenteeism - Presenteeism

Employee & Customer Dissatisfaction:

F

M

T

O

12

69% of medical costs are due to productivity loss

50% of all medical costs can be saved with integrated and comprehensive health management.

Workers Compensation

Salary Continuation

Dissatisfaction:- Turnover + Temporary Staffing- Poor Quality

Replacement Workers:- Training Interim Employee- Administrative re-work

75% caused by chronic diseases that are preventable

Source: An Unhealthy America: The Economic Burden of Chronic Disease, The Milken Institute Center for Health Economics

Page 13: 2nd Annual OTC Pharma Asia 2012

Health and Wellness: Shift in Healthcare Trends From Treatment to Prevention

Healthcare Spending Per Capita (2007, 2050)

In most countries worldwide, per capita In most countries worldwide, per capita

healthcare spending is rising faster than per healthcare spending is rising faster than per

capita income which is unsustainable capita income which is unsustainable

If current trends hold If current trends hold -- by 2050, healthcare by 2050, healthcare

spending will double, claiming 20spending will double, claiming 20--30% of 30% of

GDP for some economies GDP for some economies

Prevention trends result in greater demand for areas such as weight management and functional foods and beverages

F

M

T

O

13

Due to rising costs of healthcare, future Due to rising costs of healthcare, future

spending will move away from spending will move away from

treatment treatment

Healthcare Spending by Type of Activity

Source: Frost & Sullivan

Page 14: 2nd Annual OTC Pharma Asia 2012

KEY EMERGING OTC MARKETS

14

KEY EMERGING OTC MARKETS

Page 15: 2nd Annual OTC Pharma Asia 2012

South East Asia is Becoming World’s Hospital

Thailand�One Bangkok hospital

(Bumrungrad) served over 500,000 health tourists last year

Mexico�StarMedica hospital groups built 7

hospitals in last 5 years;�AmeriMed opening 10 new hospitals

by 2012; �GrupoAngeles (largest private

hospital group in Mexico) spending $700 million to build 15 hospitals in the next 3 years

Central Europe� Increased Medical Tourism Traffic

from Western Europe

Korea�New Entrants with strong

healthcare system offerings

15

Costa Rica�One in five visitors is a medical

tourist

Malaysia�Medical tourism as an

economic thrust

India�Government investing $3.6 Billion

in medical tourism infrastructure.�Estimates show Indian medical

tourism at $2.3B by 2012

offerings

Singapore�More internationally

accredited hospital facilities than any other country

Source: Frost & Sullivan

Page 16: 2nd Annual OTC Pharma Asia 2012

Increased Prosperity and Middle Class Consumption will Fuel Healthcare Expenditure

Other Asia9%

India4%

China2%

Japan8%

EU30%

US21%

Other26%

Middle Class Consumption (2009)

Other Asia14%

India23%

China18%

Japan4%

EU14%

US7%

Other20%

Middle Class Consumption (2030)

16

•Middle class consumption in China and India will surpass that of EU and US by 2030

•APAC will contribute to 59% of global middle class consumption by 2030, rising from 23% in 2009

•Over half of the middle class will be from the APAC region by 2020

•Both factors will be a major growth driver for HC expenditure and the growth of the HC delivery market as demand increases across the region

1810

36

22

28

53

2 26 5

0

20

40

60

80

100

2010 2020

Origins of Global Middle Class (%)

Middle East and North Africa

Sub-Saharan Africa

Asia Pacific

Central and South America

EU

North America

Source: OECD, Smith Barney, Frost & Sullivan

Page 17: 2nd Annual OTC Pharma Asia 2012

2.0%

4.0%

6.0%

8.0%

10.0%

12.0%

50.0

100.0

150.0

200.0

250.0

300.0

350.0

400.0

Pe

rce

nta

ge o

f A

ged

65

an

d A

bo

ve t

o

Tota

l Po

pu

lati

on

(%

)

Po

pu

lati

on

(M

illio

n)

By 2020, two-third of the Asia-pacific population over 65 years will have at least one chronic disease

Healthcare Industry: Population Aged 65 and Above, (Asia Pacific), 2009-2020

The Burden of Disease in elderly, Asia Pacific

17

0.0%

2.0%

-

50.0

2010 2015 2020

Pe

rce

nta

ge o

f A

ged

65

an

d A

bo

ve t

o

Tota

l Po

pu

lati

on

(%

)

Year

Aged 65 and Above (Million)

Percentage of Aged 65 and Above to Total Population (%)

� In 2010, 7.6% (241.7 million) of the Asia Pacific population was aged 65 and above.

� By 2020, this will be more than 9.7% (333.95)

� 65.2% of those aged 65+ have one chronic condition

Source: WHO, Frost & Sullivan

Page 18: 2nd Annual OTC Pharma Asia 2012

Globalization, consumerism, and prosperity are the 3 major trends that will impact healthcare

Globalization

Globalization:

• World is becoming smaller: cheap air- travel, connectivity,

internet, medical tourism

• Increased healthcare awareness because of multiple media

Consumerism:

• Increased self medicating behaviour; ease of access (online)

• Increased expression of consumer individuality through

brand choices

1

3

1

18

ConsumerismProsperity

brand choices

Prosperity:

• Increasing disposable income, financial independence

leading to exploring more choices

• Increased health awareness has led to consumers spending

more on health prevention and OTC

2

2 3

Source: Frost & Sullivan

Page 19: 2nd Annual OTC Pharma Asia 2012

8

10

12

14

16

18

Total Pharma & OTC market in SEAMEA, USD Bn 2011

Key emerging markets in SEAMEAU

SD

Bn

%

19

0

2

4

6

Total Pharma sales (USD bn) OTC sales 2011 (USD bn) OTC sales CAGR(2011-2015)

Source: Frost & Sullivan analysis, Data monitor, BMI, Deloitte,, EIU, NCB

US

D

Page 20: 2nd Annual OTC Pharma Asia 2012

Top market segments in key geographies

Indonesia

• Traditional medicines

• Topical / skin products

Vietnam

• Traditional medicines

• Cough, cold

Turkey

• Cough, cold

• Eye drops

• Vitamins and

Philippines

• Traditional medicines

• Analgesics

20

products

• Analgesics• Analgesics

• Vitamins and skin care treatment

In African countries the key market segments are analgesics, vitamins, and cough, cold medications

Source: Frost & Sullivan analysis, Data monitor, BMI, Deloitte,, EIU, NCB

Page 21: 2nd Annual OTC Pharma Asia 2012

Ease of doing business ranking

Ease of Doing Business Ranking

Saudi Arabia Mauritius Ghana Turkey Zambia Vietnam Kenya Uganda Tanzania Indonesia India Nigeria Philippines Malawai

12 23 63 71 84 98 109 123 127 129 132 133 136 145

21

Mauritius has a very small market (14m) with low growth (6%); Saudi Arabia market is ~350mn growing at 11%

Source: World bank

Page 22: 2nd Annual OTC Pharma Asia 2012

Challenges

Regulations /

RegistrationImporting vs.

Manufacturing

22

Distributors / End sales channels

Marketing / Consumers

Source: Frost & Sullivan

Page 23: 2nd Annual OTC Pharma Asia 2012

Summary

• Health care paradigm shift toward patient-centric model will

boost consumerism

• OTC markets in most emerging countries are expected to grow at

double digit CAGRs

23

• There are challenges in these markets; but these can be

overcome by adopting suitable market entry strategies

Page 24: 2nd Annual OTC Pharma Asia 2012

Opportunities exist; it is about making the right choices…

24

Page 25: 2nd Annual OTC Pharma Asia 2012

Follow Frost & Sullivan on Facebook, LinkedIn, SlideShare, and Twitter

http://www.facebook.com/FrostandSullivan

http://www.linkedin.com/companies/4506

25

http://twitter.com/frost_sullivan

http://www.linkedin.com/companies/4506

http://www.slideshare.net/FrostandSullivan

Page 26: 2nd Annual OTC Pharma Asia 2012

Thank you

Dr. Milind Sabnis, MD, MBA

Principal ConsultantHealthcare, Asia [email protected]

Donna Jeremiah,

Director, Corporate Communications Asia Pacific

61 2 8247 8927

[email protected]

26

Carrie Low

Corporate Communications

Asia Pacific

+603 6204 5910

[email protected]

Jessie Loh

Corporate Communications

Asia Pacific

+65 6890 0942

[email protected]